Detalhe da pesquisa
1.
MRD at the end of induction and EFS in T-cell lymphoblastic lymphoma: Children's Oncology Group trial AALL1231.
Blood;
143(20): 2053-2058, 2024 May 16.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38457359
2.
Central nervous system status is prognostic in T-cell acute lymphoblastic leukemia: a Children's Oncology Group report.
Blood;
141(15): 1802-1811, 2023 04 13.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36603187
3.
Prognostic significance of ETP phenotype and minimal residual disease in T-ALL: a Children's Oncology Group study.
Blood;
142(24): 2069-2078, 2023 12 14.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37556734
4.
Genomic landscape of Down syndrome-associated acute lymphoblastic leukemia.
Blood;
142(2): 172-184, 2023 07 13.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37001051
5.
Quantification of measurable residual disease using duplex sequencing in adults with acute myeloid leukemia.
Haematologica;
109(2): 401-410, 2024 Feb 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37534515
6.
2021 Update on MRD in acute myeloid leukemia: a consensus document from the European LeukemiaNet MRD Working Party.
Blood;
138(26): 2753-2767, 2021 12 30.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34724563
7.
Relative impact of residual cytogenetic abnormalities and flow cytometric measurable residual disease on outcome after allogeneic hematopoietic cell transplantation in adult acute myeloid leukemia.
Haematologica;
108(2): 420-432, 2023 02 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35924583
8.
Updates on lymphoblastic leukemia/lymphoma classification and minimal/measurable residual disease analysis.
Semin Diagn Pathol;
40(6): 457-471, 2023 Nov.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37953192
9.
Sex-based disparities in outcome in pediatric acute lymphoblastic leukemia: a Children's Oncology Group report.
Cancer;
128(9): 1863-1870, 2022 05 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35201611
10.
Inhibition of the Sec61 translocon overcomes cytokine-induced glucocorticoid resistance in T-cell acute lymphoblastic leukaemia.
Br J Haematol;
198(1): 137-141, 2022 07.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35434798
11.
Nelarabine, etoposide, and cyclophosphamide in relapsed pediatric T-acute lymphoblastic leukemia and T-lymphoblastic lymphoma (study T2008-002 NECTAR).
Pediatr Blood Cancer;
69(11): e29901, 2022 Nov.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35989458
12.
γ-Secretase inhibition increases efficacy of BCMA-specific chimeric antigen receptor T cells in multiple myeloma.
Blood;
134(19): 1585-1597, 2019 11 07.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31558469
13.
Inherited genetic susceptibility to acute lymphoblastic leukemia in Down syndrome.
Blood;
134(15): 1227-1237, 2019 10 10.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31350265
14.
Outcomes after late bone marrow and very early central nervous system relapse of childhood B-acute lymphoblastic leukemia: a report from the Children's Oncology Group phase III study AALL0433.
Haematologica;
106(1): 46-55, 2021 01 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32001530
15.
Late isolated central nervous system relapse in childhood B-cell acute lymphoblastic leukemia treated with intensified systemic therapy and delayed reduced dose cranial radiation: A report from the Children's Oncology Group study AALL02P2.
Pediatr Blood Cancer;
68(12): e29256, 2021 12.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34302704
16.
Prognostic impact of minimal residual disease at the end of consolidation in NCI standard-risk B-lymphoblastic leukemia: A report from the Children's Oncology Group.
Pediatr Blood Cancer;
68(4): e28929, 2021 04.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33559396
17.
Mixed-phenotype acute leukemia: A cohort and consensus research strategy from the Children's Oncology Group Acute Leukemia of Ambiguous Lineage Task Force.
Cancer;
126(3): 593-601, 2020 02 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31661160
18.
Blinatumomab versus Chemotherapy for Advanced Acute Lymphoblastic Leukemia.
N Engl J Med;
376(9): 836-847, 2017 03 02.
Artigo
em Inglês
| MEDLINE
| ID: mdl-28249141
19.
Minimal/measurable residual disease in AML: a consensus document from the European LeukemiaNet MRD Working Party.
Blood;
131(12): 1275-1291, 2018 03 22.
Artigo
em Inglês
| MEDLINE
| ID: mdl-29330221
20.
Preclinical efficacy of daratumumab in T-cell acute lymphoblastic leukemia.
Blood;
131(9): 995-999, 2018 03 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-29305553